Executive

GREGORY MOSS-SMITH - Chief Executive Officer.
MSc, MBA, IP Law (Franklin Pierce)

Mr Moss-Smith has 15 years of general management experience as a senior executive in the biopharmaceuticals sector and has been Chief Executive Officer of Photonz since late 2008.

Previously part of the management team that integrated four companies to form Novozymes Biopharma, he served as Global Sales Director for the newly formed business. He was also responsible for establishing the company's worldwide sales organisation based out of Cambridge, Massachusetts.

Greg was previously the head of commercial operations of the successful Australian public biotechnology company, GroPep Ltd, where he built a team responsible for sales, marketing, business development, general legal and intellectual property management. He managed the company's commercial operations from 1997 through to the IPO in 2000 and its subsequent acquisition by Novozymes A/S in 2007.

Greg's prior roles have included General Manager of Contract Manufacturing at GroPep Limited, Alternate Director of TGR Biosciences Pty Ltd, Director of the Cooperative Research Centre for Tissue Growth & Repair, Director & General Manager of Independent Biologics Ltd, Facilitator of the (NZ) National Science Strategy for Fisheries & Aquaculture and he was the founding manager of the Technology for Business Growth programme at the Foundation for Research, Science & Technology (NZ).

RICHARD JUSTICE - Chief Financial Officer.
BCOM, MBA, ACA, CMA, ACIS

Mr Justice is Chief Financial Officer of Photonz and has extensive financial and general management experience in both public and private companies in the biotechnology and IT sectors.

Most recently, Richard was CFO of Living Cell Technologies Ltd, a NZ headquartered biotech company listed on the ASX in Australia ("LCT") and on the OTCQX in the United States ("LVCLY"). Previously, he was CEO (and prior to that COO and CFO) of Brocker Technology Group Ltd ("BKI"), which was a major Information Technology company in New Zealand, initially listed on the ASE in Alberta, Canada and subsequently migrated to the Toronto Stock Exchange and then the NASDAQ.

At both Living Cell Technologies and Brocker Technologies Richard was responsible for leading the listing process and has been involved in capital raising activities in New Zealand, Australia, Canada, the United Kingdom and the United States.

HYWEL GRIFFITHS - Chief Scientific Officer.
MA(CANTAB), PHD(CANTAB)

Dr Griffiths is Chief Scientific Officer for Photonz. He studied Natural Sciences at Gonville and Cauis College, Cambridge, England where he graduated top of his class in microbial genetics.

He then went on to complete a Ph.D., also with the University of Cambridge. After undertaking post-doctural research at the Institute for Cell and Molecular Biology in Uppsala, Sweden, Hywel contributed to the development of a molecular diagnostic technology at the University of Wales in Aberystwyth. He has been leading the process development team at Photonz since 2006.